NYSE:SOLV - New York Stock Exchange, Inc. - US83444M1018 - Common Stock - Currency: USD
73.02
-1.48 (-1.99%)
The current stock price of SOLV is 73.02 USD. In the past month the price decreased by -0.79%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 29.9 | 45.13B | ||
COO | COOPER COS INC/THE | 23.91 | 17.66B | ||
ALGN | ALIGN TECHNOLOGY INC | 20.39 | 14.22B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 30.7 | 6.01B | ||
BLCO | BAUSCH + LOMB CORP | 25.4 | 5.55B | ||
LNTH | LANTHEUS HOLDINGS INC | 11.27 | 5.44B | ||
ICUI | ICU MEDICAL INC | 27.69 | 3.85B | ||
XRAY | DENTSPLY SIRONA INC | 10.14 | 3.73B | ||
HAE | HAEMONETICS CORP/MASS | 14.9 | 3.17B | ||
NEOG | NEOGEN CORP | 25.1 | 2.18B | ||
UFPT | UFP TECHNOLOGIES INC | 36.31 | 1.95B | ||
RXST | RXSIGHT INC | N/A | 1.19B |
Solventum Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in St. Paul, Minnesota and currently employs 22,007 full-time employees. The company went IPO on 2024-03-26. Solventum Corp. is a global healthcare company. Its segments include Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration. Medical Surgical is a provider of solutions including advanced wound care, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. Dental Solutions provides dental and orthodontic products include brackets, aligners, restorative cements, and bonding agents that span the life of the tooth, including products designed for preventative dental care, direct and indirect restoration, and broad orthodontic needs. Health Information Systems offers healthcare systems with software solutions, including computer-assisted physician documentation, direct-to-bill and coding automation, speech recognition, and data visualization platforms. Purification and Filtration is a provider of purification and filtration technologies including filters, purifiers, cartridges, and membranes.
SOLVENTUM CORP
C/O 3M Company, 3M Center, Building 275-6W-02
ST. PAUL MINNESOTA US
Employees: 22007
Company Website: https://www.solventum.com/en-us/home/
Phone: 16517331110
The current stock price of SOLV is 73.02 USD. The price decreased by -1.99% in the last trading session.
The exchange symbol of SOLVENTUM CORP is SOLV and it is listed on the New York Stock Exchange, Inc. exchange.
SOLV stock is listed on the New York Stock Exchange, Inc. exchange.
17 analysts have analysed SOLV and the average price target is 75.24 USD. This implies a price increase of 3.04% is expected in the next year compared to the current price of 73.02. Check the SOLVENTUM CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SOLVENTUM CORP (SOLV) has a market capitalization of 12.61B USD. This makes SOLV a Large Cap stock.
SOLVENTUM CORP (SOLV) currently has 22007 employees.
SOLVENTUM CORP (SOLV) has a support level at 71.51 and a resistance level at 73.94. Check the full technical report for a detailed analysis of SOLV support and resistance levels.
The Revenue of SOLVENTUM CORP (SOLV) is expected to grow by 2.44% in the next year. Check the estimates tab for more information on the SOLV EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SOLV does not pay a dividend.
SOLVENTUM CORP (SOLV) will report earnings on 2025-02-27, after the market close.
The PE ratio for SOLVENTUM CORP (SOLV) is 17.55. This is based on the reported non-GAAP earnings per share of 4.16 and the current share price of 73.02 USD. Check the full fundamental report for a full analysis of the valuation metrics for SOLV.
The outstanding short interest for SOLVENTUM CORP (SOLV) is 3.22% of its float. Check the ownership tab for more information on the SOLV short interest.
ChartMill assigns a technical rating of 5 / 10 to SOLV.
ChartMill assigns a fundamental rating of 3 / 10 to SOLV. While SOLV is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months SOLV reported a non-GAAP Earnings per Share(EPS) of 4.16. The EPS increased by 0.22% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 8.76% | ||
ROA | 4.88% | ||
ROE | 22.56% | ||
Debt/Equity | 2.45 |
ChartMill assigns a Buy % Consensus number of 55% to SOLV. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of -13.93% and a revenue growth 2.44% for SOLV